| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61804-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-60497-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61788-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37302-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52498-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50194-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52470-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50217-0.025ml | |||
![Western Blot: KA2/GRIK5/Glutamate Receptor KA2 Antibody (4G5H8) [NBP2-61804] - Analysis using GRIK5 mAb against human GRIK5 (AA: extra 21-166) recombinant protein. (Expected MW is 39 kDa)](http://images.novusbio.com/fullsize/KA2-GRIK5-Glutamate-Receptor-KA2-Antibody-4G5H8-Western-Blot-NBP2-61804-img0002.jpg "Western Blot: KA2/GRIK5/Glutamate Receptor KA2 Antibody (4G5H8) [NBP2-61804] - Analysis using GRIK5 mAb against human GRIK5 (AA: extra 21-166) recombinant protein. (Expected MW is 39 kDa)")
![Western Blot: KA2/GRIK5/Glutamate Receptor KA2 Antibody (4G5H8) [NBP2-61804] - Analysis using GRIK5 mAb against HEK293 (1) and GRIK5 (AA: extra 21-166)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/KA2-GRIK5-Glutamate-Receptor-KA2-Antibody-4G5H8-Western-Blot-NBP2-61804-img0003.jpg)
![ELISA: KA2/GRIK5/Glutamate Receptor KA2 Antibody (4G5H8) [NBP2-61804] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/KA2-GRIK5-Glutamate-Receptor-KA2-Antibody-4G5H8-ELISA-NBP2-61804-img0001.jpg)
![Western Blot: gamma-Synuclein Antibody (1H10D2) [NB110-60497] - Analysis using mouse mAb against truncated SNCG recombinant protein.](http://images.novusbio.com/fullsize/Synuclein-gamma-Antibody-1H10D2-Western-Blot-NB110-60497-img0002.jpg "Western Blot: gamma-Synuclein Antibody (1H10D2) [NB110-60497] - Analysis using mouse mAb against truncated SNCG recombinant protein.")
![Immunohistochemistry-Paraffin: gamma-Synuclein Antibody (1H10D2) [NB110-60497] - Analysis of human ovary carcinoma (left) and breast carcinoma (right), showing cytoplasmic(ovary carcinoma) localization, cytoplasmic and nuclear (breast carcinoma) localization using SNCG mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Synuclein-gamma-Antibody-1H10D2-Immunohistochemistry-Paraffin-NB110-60497-img0004.jpg)
![Western Blot: Glutamate Receptor 6 Antibody (8A1F11) [NBP2-61788] - Analysis using GRIK2 mAb against human GRIK2 (AA: extra 45-226) recombinant protein. (Expected MW is 46.5 kDa)](http://images.novusbio.com/fullsize/Glutamate-Receptor-6-Antibody-8A1F11-Western-Blot-NBP2-61788-img0002.jpg "Western Blot: Glutamate Receptor 6 Antibody (8A1F11) [NBP2-61788] - Analysis using GRIK2 mAb against human GRIK2 (AA: extra 45-226) recombinant protein. (Expected MW is 46.5 kDa)")
![Western Blot: Glutamate Receptor 6 Antibody (8A1F11) [NBP2-61788] - Analysis using GRIK2 mAb against HEK293 (1) and GRIK2 (AA: extra 45-226)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Glutamate-Receptor-6-Antibody-8A1F11-Western-Blot-NBP2-61788-img0003.jpg)
![ELISA: Glutamate Receptor 6 Antibody (8A1F11) [NBP2-61788] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Glutamate-Receptor-6-Antibody-8A1F11-ELISA-NBP2-61788-img0001.jpg)
![Western Blot: DARPP-32 Antibody (2A4G9) [NBP2-37302] - Western blot analysis using PPP1R1B mAb against HEK293 (1) and PPP1R1B (AA: 95-204)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/DARPP-32-Antibody-2A4G9-Western-Blot-NBP2-37302-img0003.jpg "Western Blot: DARPP-32 Antibody (2A4G9) [NBP2-37302] - Western blot analysis using PPP1R1B mAb against HEK293 (1) and PPP1R1B (AA: 95-204)-hIgGFc transfected HEK293 (2) cell lysate.")
![Western Blot: DARPP-32 Antibody (2A4G9) [NBP2-37302] - Western blot analysis using PPP1R1B mAb against human PPP1R1B (AA: 95-204) recombinant protein. (Expected MW is 38.3 kDa)](http://images.novusbio.com/fullsize/DARPP-32-Antibody-2A4G9-Western-Blot-NBP2-37302-img0002.jpg)
![ELISA: DARPP-32 Antibody (2A4G9) [NBP2-37302] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/DARPP-32-Antibody-2A4G9-ELISA-NBP2-37302-img0001.jpg)
![Western Blot: Kv4.2 Antibody (7G6A10) [NBP2-52498] - Analysis using KCND2 mAb against human KCND2 (AA: 27-184) recombinant protein. (Expected MW is 42.3 kDa)](http://images.novusbio.com/fullsize/Kv4-2-Antibody-7G6A10-Western-Blot-NBP2-52498-img0001.jpg "Western Blot: Kv4.2 Antibody (7G6A10) [NBP2-52498] - Analysis using KCND2 mAb against human KCND2 (AA: 27-184) recombinant protein. (Expected MW is 42.3 kDa)")
![Western Blot: Kv4.2 Antibody (7G6A10) [NBP2-52498] - Analysis using KCND2 mAb against HEK293 (1) and KCND2 (AA: 27-184)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Kv4-2-Antibody-7G6A10-Western-Blot-NBP2-52498-img0002.jpg)
![ELISA: Kv4.2 Antibody (7G6A10) [NBP2-52498] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/Kv4-2-Antibody-7G6A10-ELISA-NBP2-52498-img0003.jpg)
![Western Blot: Dopamine beta-Hydroxylase Antibody [NB300-111] - Western blot of human adrenal medulla. The antibody is specific for the ~75kDa DBH protein.](http://images.novusbio.com/fullsize/Dopamine-beta-Hydroxylase-Antibody-Western-Blot-NB300-111-img0006.jpg "Western Blot: Dopamine beta-Hydroxylase Antibody [NB300-111] - Western blot of human adrenal medulla. The antibody is specific for the ~75kDa DBH protein.")
![Western Blot: Dopamine beta-Hydroxylase Antibody [NB300-111] - Western blot of human adrenal medulla lysate showing specific immunolabeling of the ~75k DBH protein.](http://images.novusbio.com/fullsize/Dopamine-beta-Hydroxylase-Antibody-Western-Blot-NB300-111-img0005.jpg)
![Western Blot: CYP46A1 Antibody (N8-P6E4-H8) [NBP2-50194] - The left hand lane contains control cell lysate while the right hand lane contains lysate prepared from cells over-expressing the protein. ~15 micrograms of protein were loaded per well. No bands were detected with the negative control lysate, while a band migrating at the expected molecular weight was observed in the over-expression lysate.](http://images.novusbio.com/fullsize/CYP46A1-Antibody-N8-P6E4-H8-Western-Blot-NBP2-50194-img0002.jpg "Western Blot: CYP46A1 Antibody (N8-P6E4-H8) [NBP2-50194] - The left hand lane contains control cell lysate while the right hand lane contains lysate prepared from cells over-expressing the protein. ~15 micrograms of protein were loaded per well. No bands were detected with the negative control lysate, while a band migrating at the expected molecular weight was observed in the over-expression lysate.")
![Immunohistochemistry: CYP46A1 Antibody (N8-P6E4-H8) [NBP2-50194] - Shows strong cytoplasmic staining in metastatic colorectal cancer (A) and primary colorectal (B) compared to normal colon mucosa (C).](http://images.novusbio.com/fullsize/CYP46A1-Antibody-N8-P6E4-H8-Immunohistochemistry-NBP2-50194-img0001.jpg)
![Western Blot: GAD2/GAD65 Antibody (5D9G9) [NBP2-52470] - Analysis using GAD2 mAb against human GAD2 (AA: 1-100) recombinant protein. (Expected MW is 36.3 kDa)](http://images.novusbio.com/fullsize/GAD2-GAD65-Antibody-5D9G9-Western-Blot-NBP2-52470-img0001.jpg "Western Blot: GAD2/GAD65 Antibody (5D9G9) [NBP2-52470] - Analysis using GAD2 mAb against human GAD2 (AA: 1-100) recombinant protein. (Expected MW is 36.3 kDa)")
![Western Blot: GAD2/GAD65 Antibody (5D9G9) [NBP2-52470] - Analysis using GAD2 mAb against HEK293 (1) and GAD2 (AA: 1-100)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/GAD2-GAD65-Antibody-5D9G9-Western-Blot-NBP2-52470-img0002.jpg)
![ELISA: GAD2/GAD65 Antibody (5D9G9) [NBP2-52470] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/GAD2-GAD65-Antibody-5D9G9-ELISA-NBP2-52470-img0003.jpg)
![Western Blot: Tau [p Ser416] Antibody [NB110-93503] - Rat brain homogenate showing specific immunolabeling of the ~59, 65, 68k Tau isoforms phosphorylated at Ser416(control). Imunolabeling is blocked by preadsorption with the phospho-peptide used as antigen (Peptide) but not by the corresponding dephospho-peptide (not shown).](http://images.novusbio.com/fullsize/Tau-[p-Ser416]-Antibody-Western-Blot-NB110-93503-img0001.jpg "Western Blot: Tau [p Ser416] Antibody [NB110-93503] - Rat brain homogenate showing specific immunolabeling of the ~59, 65, 68k Tau isoforms phosphorylated at Ser416(control). Imunolabeling is blocked by preadsorption with the phospho-peptide used as antigen (Peptide) but not by the corresponding dephospho-peptide (not shown).")
![Western Blot: CYP7B1 Antibody (M17-P3F2) [NBP2-50217] - Western blot was performed using anti-Cytochrome P450 7B1 [M17-P3F2]. The left hand lane contains control cell lysate while the right hand lane contains lysate prepared from cells over-expressing the protein. ~15 micrograms of protein were loaded per well. No bands were detected with the negative control lysate, while a band migrating at the expected molecular weight was observed in the over-expression lysate.](http://images.novusbio.com/fullsize/CYP7B1-Antibody-M17-P3F2-Western-Blot-NBP2-50217-img0002.jpg "Western Blot: CYP7B1 Antibody (M17-P3F2) [NBP2-50217] - Western blot was performed using anti-Cytochrome P450 7B1 [M17-P3F2]. The left hand lane contains control cell lysate while the right hand lane contains lysate prepared from cells over-expressing the protein. ~15 micrograms of protein were loaded per well. No bands were detected with the negative control lysate, while a band migrating at the expected molecular weight was observed in the over-expression lysate.")
![Immunohistochemistry-Paraffin: CYP7B1 Antibody (M17-P3F2) [NBP2-50217] - Shows positive cytoplasmic immunostaining in normal liver (A) which is expected as CYP7B1 is involved in bile acid synthesis. Primary colorectal (B) and metastatic colorectal tumors (C) showed stronger staining compared to normal colon mucosa (D).](http://images.novusbio.com/fullsize/CYP7B1-Antibody-M17-P3F2-Immunohistochemistry-Paraffin-NBP2-50217-img0001.jpg)
![Western Blot: Dynamin Antibody [NB100-61094] - Western Blot of rat cortex lysate using NB100-61094 at 1:1000.](http://images.novusbio.com/fullsize/Dynamin-Antibody-Western-Blot-NB100-61094-img0002.jpg "Western Blot: Dynamin Antibody [NB100-61094] - Western Blot of rat cortex lysate using NB100-61094 at 1:1000.")
![Western Blot: Dynamin Antibody [NB100-61094] - Rat cortex lysate showing labeling of the ~95k Dynamin protein.](http://images.novusbio.com/fullsize/Dynamin-Antibody-Western-Blot-NB100-61094-img0001.jpg)
![Western Blot: Synapsin I [p Ser62, p Ser67] Antibody [NB300-745] - Western blot of rat cortex lyaste showing specific labeling of the ~78k Synapsin protein phosphorylated at Ser62,67 (Control). Immunolabeling is blocked by preadsorption with the phospho-peptide used as antigen (Peptide) but not by the corresponding dephospho-peptide (not shown).](http://images.novusbio.com/fullsize/Synapsin-I-[p-Ser62-p-Ser67]-Antibody-Western-Blot-NB300-745-img0001.jpg "Western Blot: Synapsin I [p Ser62, p Ser67] Antibody [NB300-745] - Western blot of rat cortex lyaste showing specific labeling of the ~78k Synapsin protein phosphorylated at Ser62,67 (Control). Immunolabeling is blocked by preadsorption with the phospho-peptide used as antigen (Peptide) but not by the corresponding dephospho-peptide (not shown).")